In colorectal cancer, sHLA-G levels in plasma were positively correlated with the number of metastatic sites [139, 140] and inversely related to survival [108], whereas high levels of sHLA-G in saliva were suggestive of later disease stage [141]. This evidence concerns the gene HLA-G and colorectal cancer.